Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webst...

FDA Recall #D-0254-2026 — Class II — December 16, 2025

Recall #D-0254-2026 Date: December 16, 2025 Classification: Class II Status: Ongoing

Product Description

Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0523-01.

Reason for Recall

Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.

Recalling Firm

SpecGx, LLC — Webster Groves, MO

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

287,988 Bottles.

Distribution

Nationwide

Code Information

Lot: 0523J23904, expires: 05/2027; 0523J24426, 0523J24427, expires: 06/2027.

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated